$TATT Balance Sheet | Understand Stock

$TATT

$32.96 +$0.28 (0.86%) Live

$TATT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q4 FY2013 As of Dec 31, 2013
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Short-term bank deposits
Accounts receivable, net of allowance for credit losses of $172 and $400 thousands as of December 31, 2025 and 2024, respectively
Restricted deposit
Inventory
Assets held for sale
Prepaid expenses and other current assets
Assets belong to discontinued operation
Total current assets

NON-CURRENT ASSETS:
Property, plant and equipment, net
Operating lease right of use assets
Intangible assets, net
Assets belong to discontinued operation
Investment in affiliates
Restricted deposit
Funds in respect of employee rights upon retirement
Deferred income taxes
Total investment and other non current assets
Deferred tax assets
Total non-current assets

Total assets
LIABILITIES AND SHAREHOLDERS 'EQUITY
CURRENT LIABILITIES:
Short term bank loan and current maturities of long-term loans
Current maturities of long-term loans
Short term loans
Accounts payable
Accrued compensation and related expenses
Other accrued liabilities
Accrued expenses and other
Liabilities held for sale
Current maturities of operating lease liabilities
Provision for restructuring plan
Liabilities belong to discontinued operation
Total current liabilities

NON-CURRENT LIABILITIES:
Long-term loans
Other long-term liabilities
Operating lease liabilities
Liability in respect of employee rights upon retirement
Deferred income taxes
Deferred tax liabilities
Total non-current liabilities

Total liabilities
SHAREHOLDERS 'EQUITY:
Ordinary shares of NIS 0 par value. Authorized: 19,000,000 shares at December 31, 2025 and 13,000,000 shares at December 31, 2024 Issued:13,257,610 and 11,214,831 shares at December 31, 2025 and 2024, respectively Outstanding: 12,983,137 and 10,940,358 shares at December 31, 2025 and 2024, respectively
Additional paid-in capital
Treasury shares, at cost, 274,473 shares at December 31, 2025 and 2024
Accumulated other comprehensive income (loss)
Retained earnings
Non-controlling interest
Total shareholders' equity

Total liabilities and shareholders' equity

Comments